DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Panacea Biotec Q2 FY27: Date and Expectations

Univest 18 hrs ago·10 Sept 2026, 6:12 pm

Panacea Biotec is set to announce its financial results for the second quarter of fiscal year 2027. The company, known for its vaccines and pharmaceuticals, will release its earnings report on the scheduled date. Investors are keen to see how the company performed during this period, especially given the ongoing competitive landscape in the healthcare sector.

This earnings announcement is significant for stakeholders as it provides insights into the company's operational health and growth trajectory. Key metrics to watch include revenue growth, profit margins, and updates on key product launches. Positive results could boost investor confidence, while any concerns might lead to volatility in the stock price.

Moving forward, market participants will closely monitor the management's commentary on future outlook and strategic initiatives. Any guidance provided during the earnings call will be crucial for assessing the company's potential in the coming quarters.